Schedule 13G ownership disclosure

INOZYME PHARMA INC

Security class unavailable · CUSIP: 45790W108

Event date: 2021-11-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-139246
Form type
SC 13G/A
Filer
Inozyme Pharma, Inc.
CIK
CIK 1693011
Filed
Nov 15, 2021
Reporting period
Nov 15, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub